NCT00634504 2022-06-06
LVPK
BTG International Inc.
Phase 1 Completed
Clinical Trials
5 trialsNCT01305655 2018-09-28
NOPHOCPG2
Nordic Society for Pediatric Hematology and Oncology
Phase 3 Completed
NCT00018967 2015-04-30
Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate
National Cancer Institute (NCI)
Phase NA Completed
NCT00219791 2014-09-11
Study of Glucarpidase (CPG2) for the Management of Patients With Delayed Methotrexate Clearance
BTG International Inc.
Phase 2 Completed
NCT00727831 2014-01-27
Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma
University College, London
Phase 1/2 Completed